Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

Podobne zapisy

• Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer
  od: Hunter, B A, i wsp.
  Wydane: (2014)
• Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial()
  od: Eustace, Amanda, i wsp.
  Wydane: (2013)
• A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer
  od: Eustace, Amanda, i wsp.
  Wydane: (2013)
• A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer
  od: Khan, Mairah T., i wsp.
  Wydane: (2021)
• Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis
  od: Blick, C, i wsp.
  Wydane: (2015)